P. Soons

发表

A Time‐to‐Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations

Å. Westin, M. Karlsson, A. Hansson, 2020, Clinical pharmacology and therapeutics.

Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects.

D. Breimer, P. Soons, J. Schellens, 1988, Biochemical pharmacology.

Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration

Å. Westin, J. P. Perez Ruixo, A. Hansson, 2020, Clinical Pharmacokinetics.

Intraindividual Variability in Nifedipine Pharmacokinetics and Effects in Healthy Subjects

H. Schoemaker, D. Breimer, A. Cohen, 1992, Journal of clinical pharmacology.

In vivo oxidative cleavage of a pyridine-carboxylic acid ester metabolite of nifedipine.

F. Guengerich, D. Breimer, P. Soons, 1989, Biochemical pharmacology.

Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study.

D. Breimer, P. van Brummelen, A. D. De Boer, 1989, British journal of clinical pharmacology.

Effects of Single‐Dose and Short‐Term Oral Nifedipine on Indocyanine Green Clearance as Assessed by Spectrophotometry and High Performance Liquid Chromatography

D. Breimer, P. Soons, J. Kroon, 1990, Journal of clinical pharmacology.

Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in man.

D. Breimer, J. H. van der Wart, P. Soons, 1991, British journal of clinical pharmacology.

Liver Blood Flow as a Major Determinant of the Clearance of Recombinant Human Tissue-Type Plasminogen Activator

H. Schoemaker, D. Breimer, A. Cohen, 1992, Thrombosis and Haemostasis.

Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.

D. Breimer, A. Cohen, A. D. De Boer, 1991, British journal of clinical pharmacology.

Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.

H. Schoemaker, D. Breimer, A. Cohen, 1993, British Journal of Clinical Pharmacology.

Effects of Acute Febrile Infectious Diseases on the Oral Pharmacokinetics and Effects of Nitrendipine Enantiomers and of Bisoprolol

W. Kirch, D. Breimer, P. Soons, 1992, Clinical pharmacokinetics.

Functioning at School Age of Moderately Preterm Children Born at 32 to 36 Weeks' Gestational Age

A. V. van Baar, P. Soons, E. Knots, 2009, Pediatrics.

Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects

M. Danhof, J. Jansen, D. Breimer, 2004, European Journal of Clinical Pharmacology.

Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma.

D. Breimer, M. Roosemalen, P. Soons, 1990, Journal of chromatography.

Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.

D. Breimer, P. Soons, 1991, British journal of clinical pharmacology.

Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

J. Donnelly, J. Mouton, A. V. van Vliet, 2006, Antimicrobial Agents and Chemotherapy.

Biosynthesis of MSH and related peptides in the pars intermedia of the mouse: A pulse-chase analysis

B. Jenks, W. Meulepas, P. Soons, 1979, Molecular and Cellular Endocrinology.

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans

B. Edgar, H. Schoemaker, D. Breimer, 1991, Clinical pharmacology and therapeutics.

Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks.

M. Ferrari, K. Roon, P. Soons, 1999, British journal of clinical pharmacology.

Loperamide and P‐glycoprotein inhibition: assessment of the clinical relevance

Yimei Xu, P. Soons, J. Vandenbossche, 2010, The Journal of pharmacy and pharmacology.

ISEC: a program to calculate insulin secretion.

R. Hovorka, R Hovorka, M. Young, 1996, Computer methods and programs in biomedicine.

Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers

D. Breimer, A. Cohen, P. Soons, 2004, European Journal of Clinical Pharmacology.

Relating Nicotine Plasma Concentration to Momentary Craving Across Four Nicotine Replacement Therapy Formulations

Å. Westin, J. P. Perez Ruixo, M. Karlsson, 2020, Clinical pharmacology and therapeutics.

Abstracts of papers Pharmacological meeting

N. Ramsey, J. M. Ree, M. Danhof, 1985, Pharmaceutisch Weekblad.

Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects.

D. Breimer, M. Roosemalen, P. Soons, 1990, British journal of clinical pharmacology.

Nifedipine: variability in its kinetics and metabolism in man.

D. Breimer, P. Soons, J. Schellens, 1989, Pharmacology & therapeutics.

Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics

H. Schoemaker, D. Breimer, A. Cohen, 2004, European Journal of Clinical Pharmacology.

Stereoselective pharmacokinetics of oral nitrendipine in elderly hypertensive patients with normal and impaired renal function

W. Kirch, D. Breimer, T. Ankermann, 1992, European Journal of Clinical Pharmacology.

Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatographic methodology.

D. Breimer, M. Roosemalen, P. Soons, 1991, Journal of pharmaceutical and biomedical analysis.

Gas chromatographic analysis of nitrendipine and its pyridine metabolite in human plasma.

D. Breimer, P. Soons, 1988, Journal of chromatography.

High-performance liquid chromatographic determination of the polar metabolites of nifedipine in plasma, blood and urine.

D. Breimer, M. Roosemalen, P. Soons, 1991, Journal of chromatography.

CODE: a deconvolution program implementing a regularization method of deconvolution constrained to non‐negative values. Description and pilot evaluation

K R Godfrey, M J Chappell, K. Godfrey, 1998, Biopharmaceutics & drug disposition.

Functioning at School Age of Moderately Preterm Children Born at 32 to 36 Weeks' Gestational Age

A. V. van Baar, P. Soons, E. Knots, 2009, Pediatrics.